MAT1A and metabolic dysfunction-associated steatotic liver disease: A comparison with the serum metabolomic profiles of Mat1a knockout mice, which develop NASH-HCC, allowed the clustering of human NAFLD patients into two groups, one with serum metabolomic profiles similar to Mat1a knockout mice (M-subtype) and a second with different profiles (non-M-subtype) [174].